Learning the Lessons of Failure: How to improve the economics of Life Sciences R&D

In this webinar discussion, Clarivate experts delve into the costly reality of failed drug and device launches within the pharmaceutical industry. With approximately 90% of candidates entering clinical trials failing to achieve regulatory approval, understanding the reasons behind these failures is crucial for companies aiming to future-proof their product candidates.

What you’ll learn:

• Explore the significant costs associated with failed drug and device launches, and the impact on pharmaceutical companies.
• Gain insights from real-world examples of drugs and devices such as bortezomib (Velcade), inhaled insulin (Exubera), Ionapegsomatropin (Sytrofa) and many more.
• How to navigate challenges from early R&D through to commercialization, avoiding common pitfalls and maximizing the potential for success.